Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,500 | 2 | 66.7% |
| Travel and Lodging | $1,249 | 2 | 23.8% |
| Food and Beverage | $495.89 | 5 | 9.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $5,096 | 7 | $0 (2019) |
| BioMarin Pharmaceutical Inc. | $124.69 | 1 | $0 (2022) |
| Novo Nordisk Inc | $24.92 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $24.92 | 1 | Novo Nordisk Inc ($24.92) |
| 2022 | $124.69 | 1 | BioMarin Pharmaceutical Inc. ($124.69) |
| 2019 | $125.00 | 1 | Alexion Pharmaceuticals, Inc. ($125.00) |
| 2017 | $4,971 | 6 | Alexion Pharmaceuticals, Inc. ($4,971) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Diabetes | ||||||
| 11/02/2022 | BioMarin Pharmaceutical Inc. | VOXZOGO (Biological) | Food and Beverage | In-kind items and services | $124.69 | General |
| Category: Achondroplasia | ||||||
| 09/21/2019 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrinology | ||||||
| 09/09/2017 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Food and Beverage | In-kind items and services | $121.89 | General |
| Category: Endocrinology | ||||||
| 02/28/2017 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Endocrinology | ||||||
| 02/17/2017 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Travel and Lodging | In-kind items and services | $752.35 | General |
| Category: Endocrinology | ||||||
| 02/16/2017 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Food and Beverage | In-kind items and services | $99.39 | General |
| Category: Endocrinology | ||||||
| 01/26/2017 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Endocrinology | ||||||
| 01/20/2017 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Travel and Lodging | In-kind items and services | $497.05 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 107 | 114 | $92,654 | $13,230 |
| 2022 | 4 | 110 | 126 | $88,088 | $12,308 |
| 2021 | 3 | 71 | 73 | $57,385 | $8,961 |
| 2020 | 3 | 64 | 67 | $47,235 | $5,380 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 42 | 49 | $37,877 | $5,916 | 15.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 34 | 34 | $36,890 | $5,167 | 14.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 31 | $17,887 | $2,147 | 12.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 36 | 36 | $39,060 | $5,415 | 13.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 27 | 32 | $24,736 | $3,655 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 36 | $20,772 | $2,660 | 12.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 14 | 22 | $3,520 | $577.88 | 16.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 38 | 39 | $30,147 | $5,079 | 16.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $16,275 | $2,332 | 14.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 19 | $10,963 | $1,549 | 14.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 25 | 26 | $20,098 | $2,141 | 10.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 29 | $16,733 | $1,930 | 11.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $10,404 | $1,309 | 12.6% |
About Dr. Roger Long, M.D
Dr. Roger Long, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285641449.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Long, M.D has received a total of $5,245 in payments from pharmaceutical and medical device companies, with $24.92 received in 2023. These payments were reported across 9 transactions from 3 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($3,500).
As a Medicare-enrolled provider, Long has provided services to 352 Medicare beneficiaries, totaling 380 services with total Medicare billing of $39,879. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Pediatric Endocrinology
- Location San Francisco, CA
- Active Since 08/01/2006
- Last Updated 09/13/2012
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285641449
Products in Payments
- Strensiq (Drug) $5,096
- VOXZOGO (Biological) $124.69
- Rybelsus (Drug) $24.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in San Francisco
Cheng-Yang Tuan, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $672,998
Dr. Nancy Bohannon, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $265,062
Lewis Blevins, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $158,184
Dr. Wade Aubry, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $104,039
Dr. Jennifer Perkins, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $84,954
Dr. Daniel Bikle, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $23,160